Published : 2017-10-25

ANTICOAGULANT THERAPY IN ACUTE CORONARY SYNDROMES AND ISCHEMIC STROKE

Natalia Cichoń

Dominika Lach

Joanna Saluk-Bijak

Michał Bijak

Abstract

Cardiovascular diseases, including acute coronary syndromes and ischemic stroke, present a serious problem to modern medicine. In Europe, they lead to 4 million deaths each year. In both diseases the main cause of ischemia is vascular occlusion. Therefore, treatment relies on drugs with a similar antithrombotic action, and includes antiplatelet and anticoagulant therapy. Anticoagulants are used to prevent thromboembolic events by inhibiting the activity of enzymes of the coagulation cascade. They include: vitamin K antagonists, thrombin inhibitors (indirect and direct) and inhibitors of factor Xa. In this paper, the current state of the field of anticoagulant therapy is discussed, as it pertains to patients with acute coronary syndrome and ischemic stroke. In addition, the differences and similarities in the treatment algorithms for these conditions are described.

Keywords:

acute coronary syndrome, ischemic stroke, antithrombotic therapy, anticoagulant therapy


Most read articles by the same author(s)


Details

References

Statistics

Authors

Download files

PDF (Język Polski)

Citation rules

Cichoń, N., Lach, D., Saluk-Bijak, J., & Bijak, M. (2017). ANTICOAGULANT THERAPY IN ACUTE CORONARY SYNDROMES AND ISCHEMIC STROKE. Prospects in Pharmaceutical Sciences, 15(5), 40–49. https://doi.org/10.56782/pps.74

Altmetric indicators


Cited by / Share


Licence


Editorial Team
Stefana Banacha 1
02-097 Warsaw, Poland
biuletynfarmacji@wum.edu.pl
Publisher:
Medical University of Warsaw
ul. Żwirki i Wigury 61
02-091 Warszawa

About:
Copyright 2021 by
OJS Support and Customization by LIBCOM
Platform & workfow by OJS/PKP